The Manufacturers Life Insurance Company Invests $1.30 Million in Ingevity Corporation $NGVT

The Manufacturers Life Insurance Company purchased a new stake in Ingevity Corporation (NYSE:NGVT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,481 shares of the company’s stock, valued at approximately $1,305,000.

A number of other hedge funds have also recently bought and sold shares of the business. Quantbot Technologies LP purchased a new position in shares of Ingevity during the 2nd quarter valued at approximately $1,598,000. Evolve Private Wealth LLC bought a new stake in shares of Ingevity in the second quarter worth $460,000. Callan Family Office LLC acquired a new stake in Ingevity in the second quarter valued at $1,083,000. Trillium Asset Management LLC bought a new position in Ingevity during the 2nd quarter valued at $6,903,000. Finally, Frazier Financial Advisors LLC bought a new position in Ingevity during the 2nd quarter valued at $37,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Stock Performance

Ingevity stock opened at $70.56 on Friday. The company has a market cap of $2.43 billion, a PE ratio of 48.00 and a beta of 1.17. The company has a fifty day moving average price of $73.06 and a two-hundred day moving average price of $71.62. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. Ingevity Corporation has a 12 month low of $45.85 and a 12 month high of $79.29.

Ingevity (NYSE:NGVT) last released its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.41. The firm had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts expect that Ingevity Corporation will post 5.4 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on NGVT shares. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $80.00.

Insider Transactions at Ingevity

In other Ingevity news, SVP Ryan Fisher sold 2,709 shares of Ingevity stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the transaction, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO David Li sold 5,000 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the sale, the chief executive officer owned 120,636 shares in the company, valued at $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,801 shares of company stock worth $1,347,481 in the last three months. 0.88% of the stock is currently owned by corporate insiders.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.